Rockefeller Capital Management
GOSS icon

Rockefeller Capital Management’s Gossamer Bio GOSS Stock Holding History

Rockefeller Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.4K Sell
1,323
-22
-2% -$491 ﹤0.01% 3778
2026
Q1 		$35.4K Buy
1,345
+584
+77% +$73.4K ﹤0.01% 3447
2025
Q4 		$189K Buy
761
+633
+495% +$144K ﹤0.01% 2409
2025
Q3 		$26.8K Buy
+128
New +$22.6K ﹤0.01% 3204
2023
Q1 		– Hold
0
– – – 2763
2022
Q4 		– Hold
0
– – – 3995
2022
Q3 		– Hold
0
– – – 4068
2022
Q2 		– Hold
0
– – – 4216
2022
Q1 		– Hold
0
– – – 3947
2021
Q4 		– Hold
0
– – – 3850
2021
Q3 		– Hold
0
– – – 3739

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Rockefeller Capital Management's GOSS Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Gossamer Bio (GOSS) stake by 1.6% in Q2 2026, selling an estimated $491 and leaving 1,323 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3778.

Rockefeller Capital Management first reported a position in GOSS in Q3 2025 and has held it in 4 quarters since. The position peaked at $189K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Rockefeller Capital Management held 1,323 shares of Gossamer Bio worth $17.4K as of Q2 2026.
  • Rockefeller Capital Management sold 22 Gossamer Bio shares in Q2 2026, an estimated $491.
  • Gossamer Bio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3778 holding.
  • Rockefeller Capital Management first reported a position in Gossamer Bio in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's Gossamer Bio position peaked at $189K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.